http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020166557-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a57036e4339d4d44cbb4ccce6c175cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
filingDate 2020-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4944ff5aa4400028a064f79161f51b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b4e588e6afc3bdf4c47d6aa5ebb3c0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2a19ffa5d7fda5b4ca4f776b3443534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c472698c551f301f043187983e10064b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_790e66d4702074ef8dbca0296bf27fdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_023ca26f6af46b5fc58b72e98863194b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_431213010135c92515737cca46da8c61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1c86154001b5788c8ec185200d09306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a199cb6033d5cea93f727d4c76e4f3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62fd24accceaaa7a4c5bfcf38bc76fc1
publicationDate 2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020166557-A1
titleOfInvention Method for treating pregancy-induced hypertension nephrosis
abstract The purpose of the present invention is to provide: a method for treating pregnancy-induced hypertension nephrosis, the method being characterized by administering antithrombin; and a novel composition for treating pregnancy-induced hypertension nephrosis, the composition comprising antithrombin. The present invention relates to: a method for treating pregnancy-induced hypertension nephrosis, the method being characterized by administering antithrombin to a pregnancy-induced hypertension nephrosis patient with 100% or lower blood antithrombin activity; and a composition for treating pregnancy-induced hypertension nephrosis, the composition comprising antithrombin and characterized in that antithrombin is administered to a pregnancy-induced hypertension nephrosis patient with 100% or lower blood antithrombin activity.
priorityDate 2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005035563-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008120801-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016159204-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1738118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226704132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45157500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251

Total number of triples: 50.